Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADAPT Phase 2
PACTR201311000659400Phase 2Completed
- Sponsor
- Liverpool School of Tropical Medicine
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2 trial of artemether + lumefantrine and dihydroartemisinin + piperaquine in malaria (2 arms), sponsored by Liverpool School of Tropical Medicine. Primary endpoint: malaria parasitemia. Started Oct 2013; status: completed.
02
Drugs
artemether + lumefantrinedihydroartemisinin + piperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR201311000659400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201311000659400.